Transaction #28866 · Form 4 · 0000105770-26-000112
WEST PHARMACEUTICAL SERVICES INC · Stock award · Phantom Stock Unit
WEST PHARMACEUTICAL SERVICES INC · Transacted September 30, 2026 · Filed October 2, 2026
What does this filing report?
An SEC Form 4 filing for WEST PHARMACEUTICAL SERVICES INC records a stock award involving Phantom Stock Unit on September 30, 2026. The reported quantity was 44. The filing date is October 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0000105770
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 44
- Reported price
- 370.76
- Reference value
- 16,313.44
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 350.87
- Ownership description
- Not reported
- SEC acceptance time
- Oct 2, 2026, 1:10 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- HAUGEN JANET BRUTSCHEA ↗
Director
CIK 0001185136
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 44
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2
- Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.